Testing effectiveness (Phase 2)Study completedNCT03893695
What this trial is testing
Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)
Who this might be right for
Metastatic Hepatocellular CarcinomaHCCCombinations of Drugs; Dependence
Suzhou Kintor Pharmaceutical Inc, 20